The responses are from January-February 2013 and feature Anthera Pharmaceuticals ANTH, Gtx Inc GTXI, ImmunoCellular Therapeutics IMUC, Pozen Inc POZN, and Rigel Pharmaceuticals RIGL.
Check out the complete index of all IR Questions and Answers.
Biotech Due Diligence |
|